Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis
Male
Aftercare
Pilot Projects
Plaque, Atherosclerotic
3. Good health
03 medical and health sciences
0302 clinical medicine
Lipoprotein(a), acute coronary syndromes, cardiovascular risk
Humans
Carotid Stenosis
Female
Acute Coronary Syndrome
Biomarkers
Aged
Lipoprotein(a)
DOI:
10.1111/eci.12888
Publication Date:
2018-01-12T02:16:46Z
AUTHORS (16)
ABSTRACT
AbstractBackgroundDifferent cut‐off values of serum lipoprotein (a) [Lp (a)] were recently identified to better stratify cardiovascular risk categories. Both pathophysiological and prognostic values of Lp (a) remain unclear.Materials and methodsHere, the prognostic value of Lp (a) and its correlation with intraplaque features were assessed in patients with severe carotid artery stenosis undergoing endarterectomy (n = 180). The cut‐off value of 10 mg/dL for serum Lp (a) was selected to predict 24‐month follow‐up acute coronary syndrome (ACS). In addition, the association between serum Lp (a) and intraplaque lipids, collagen, inflammatory and vascular cells was assessed. Serum Lp (a) levels were measured by nephelometric assay.ResultsPatients with high Lp (a) had similar comorbidities, medications and laboratory parameters as compared to low Lp (a) levels. At 24‐month follow‐up, patients with high Lp (a) had more ACS as compared to low levels. Histological parameters within plaques were comparable in the study groups. No significant correlation between Lp (a) serum levels and intraplaque parameters was found, except for a weak positive association with smooth muscle cells in upstream plaque portions. When adjusted for gender, the presence of dyslipidaemia and chronic coronary artery disease, Lp (a) ≥10 mg/dL remained predictive for ACS.ConclusionsLp (a) determination could be a useful tool to predict ACS in patients with severe carotid stenosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (13)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....